A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://link.springer.com/article/10.1007/s10439-015-1380-x below:

Coronary Stent Materials and Coatings: A Technology and Performance Update

References

  1. Abizaid, A., and J. R. Costa. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ. Cardiovasc. Interv. 3:384–393, 2010.

    Article  CAS  PubMed  Google Scholar 

  2. Basalus, M., K. Tandjung, A. Van Apeldoorn, M. J. K. Ankone, and C. Von Birgelen. Effect of oversized partial postdilation on coatings of contemporary durable polymer-based drug-eluting stents. A scanning electron microscopy study. J. Interv. Cardiol. 24:149–161, 2011.

    Article  PubMed  Google Scholar 

  3. Beijk, M., M. Klomp, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, J. G. P. Tijssen, J. J. Piek, and R. J. de Winter. Two-year follow-up of the genous endothelial progenitor capturing cell capturing stent versus the taxus liberte stent in patients with de novo coronary artery lesions with a risk of restenosis. Catheter. Cardiovasc. Interv. 78:189–195, 2011.

    Article  PubMed  Google Scholar 

  4. Beijk, M., M. Klomp, N. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, and R. J. de Winter. Genous™ endothelial progenitor cell capturing stent vs the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centred pilot study. Eur. Heart J. 31:1055–1064, 2010.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Berlin, T., E. Rozenbaum, J. Arbel, O. Reges, J. Erel, I. Shetboun, M. Leibovitch, and M. Mosseri. Six- and twelve-month clinical outcomes after implantation of prokinetic BMS in patients with acute coronary syndrome. J. Interv. Cardiol. 23:377–381, 2010.

    Article  PubMed  Google Scholar 

  6. Biosensors Press Release. BioFreedom™ FIM Trial Demonstrates Comparable Long-Term Safety and Efficacy to Conventional Drug-Eluting Stent, November 10th, 2011.

  7. Biosensors Press Release. Initial Patient Enrolled in BioFreedom USA: First Major American Trial for Biosensors BioFreedom Stent—Polymer-Free, Shorter DAPT, September 4th, 2014.

  8. Biotronik Press Release. BIOTRONIK Advances Clinical Evaluation of Latest Generation DREAMS, World’s First Bioabsorbable Magnesium Scaffold, February 19th, 2015.

  9. Biotronik Press Release. BIOTRONIK Announces Completion of Patient Enrollment in BIOFLOW-IV Study Evaluating Safety and Efficacy of Orsiro, February 4th, 2015.

  10. Biotronik Press Release. Biotronik announces first patients treated in BIOFLOW II clinical study comparing ORSIRO hybrid drug-eluting stent to Abbott’s Xience Prime, July 13th, 2011.

  11. Boston Scientific Corp Press Release. Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent, November 11th, 2011.

  12. Brophy, J. M., P. Belisle, and L. Joseph. Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann. Intern. Med. 138:777–786, 2003.

    Article  PubMed  Google Scholar 

  13. Cassese, S., G. De Luca, B. Villari, S. Berti, P. Bellone, A. Alfieri, A. Montinaro, G. Quaranta, P. Marraccini, and F. Piscione. Reduced antiplatelet therapy after drug-eluting stenting: multicenter janus Flex Carbostent implantation with short dual antiplatelet treatment for 2 or 6 months—MATRIX study. Catheter. Cardiovasc. Interv. 80:408–416, 2012.

    Article  PubMed  Google Scholar 

  14. Chavarri, M. V., A. Bethencourt, E. Pinar, A. Gomez, J. F. Portales, F. Pomar, I. Calvo, J. R. Lopez Minguez, R. Valdesuso, J. Moreu, A. Martinez, and W. Nammas. Titanium-nitride-oxide-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry. Heart Vessels 27:151–158, 2012.

    Article  PubMed  Google Scholar 

  15. Cordis announces discontinuation of NEVO sirolimus-eluting coronary stent. Company to focus on areas of significant patient need in cardiovascular disease. Cordis Press Release, June 15th, 2011.

  16. Costa, J. R., A. Abizaid, R. Costa, F. Feres, L. F. Tanajura, A. Abizaid, G. Maldonado, R. Staico, D. Siqueira, A. Sousa, R. Bonan, and J. E. Sousa. 1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions. J. Am. Coll. Cardiol. Interv. 2:422–427, 2009.

    Article  Google Scholar 

  17. Costa, J. R., B. A. Oliveira, A. Abizaid, R. Costa, M. Perin, A. Abizaid, D. Chamié, L. F. Tanajura, A. Sousa, and J. E. M. R. Sousa. Clinical, angiographic, and intravascular ultrasound results of the VestaSync II trial. Catheter. Cardiovasc. Interv. 84:1073–1079, 2014.

    Article  PubMed  Google Scholar 

  18. Desch, S., D. Schloma, S. Möbius-Winkler, S. Erbs, S. Gielen, A. Linke, J. Yu, B. Lauer, K. Kleinertz, W. Danschel, G. Schuler, and H. Thiele. Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus. J. Am. Coll. Cardiol. Interv. 4:452–459, 2011.

    Article  Google Scholar 

  19. Erbel, R., C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, F. R. Eberli, P. Erne, M. Haude, B. Heublin, M. Harrigan, C. Ilsley, D. Boese, J. Koolen, T. F. Luescher, N. Weissman, and R. Waksman. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents; a prospective non-randomized multi-centre trial. Lancet 369:1869–1875, 2007.

    Article  CAS  PubMed  Google Scholar 

  20. Felix, C., B. Everaert, R. Diletti, N. Van Mieghem, J. Daemen, M. Valgimigli, P. P. de Jaegere, F. Zijlstra, E. Regar, C. Simsek, Y. Onuma, and R. J. M. van Geuns. Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions. Neth. Heart J. 23:153–160, 2015.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Finn, A. V., M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441, 2007.

    Article  PubMed  Google Scholar 

  22. Granada, J. F., and J. W. Moses. Assessing the durability of durable stent polymers: will they pass the test of time? J. Interv. Cardiol. 24:162–164, 2011.

    Article  PubMed  Google Scholar 

  23. Grube, E., J. Schofer, K. E. Hauptmann, G. Nickenig, N. Curzen, D. J. Allocco, and K. D. Dawkins. A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer. J. Am. Coll. Cardiol. Interv. 3:431–438, 2010.

    Article  Google Scholar 

  24. Guagliumi, G., V. Sirbu, G. Musumeci, H. G. Bezerra, A. Aprile, H. Kyono, L. Fiocca, A. Matiashvili, N. Lortkipanidze, A. Vassileva, J. J. Popma, D. J. Allocco, K. D. Dawkins, O. Valsecchi, and M. A. Costa. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer. Circ. Cardiovasc. Interv. 3:367–375, 2010.

    Article  CAS  PubMed  Google Scholar 

  25. Gutiérrez-Chico, J. L., P. Jüni, H. M. García-García, E. Regar, E. Nuesch, F. Borgia, W. J. van der Giessen, S. Davies, R. J. van Geuns, G. G. Secco, S. Meis, S. Windecker, P. W. Serruys, and C. di Mario. Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer. Am. Heart J. 162:922–931, 2011.

    Article  PubMed  Google Scholar 

  26. Hanratty, C. G., and S. J. Walsh. Longitudinal compression: a “new” complication with modern coronary stent platforms—time to think beyond deliverability. EuroIntervention 7:872–877, 2011.

    Article  PubMed  Google Scholar 

  27. Haude, M. Two-Year Clinical Data and Multi-modality Imaging Results up to 1-year Follow-Up of the BIOSOLVE-I Study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS). Paris: EuroPCR, 2013.

    Google Scholar 

  28. Hermawan H, Mantovani D. New generation of medical implants: metallic biodegradable coronary stent. In: International Conference on Instrumentation, Communication, Information Technology and Biomedical Engineering, Indonesia, November 8–9, 2011.

  29. Hermawan, H., and D. Mantovani. Process of prototyping coronary stent from biodegradable Fe-Mn alloys. Acta Biomater. 9:8585–8592, 2013.

    Article  CAS  PubMed  Google Scholar 

  30. Johnson, T. W., Y. X. Wu, C. Herdeg, A. Baumbach, A. C. Newby, K. R. Karsch, and M. Oberhoff. Stent-based delivery of tissue inhibitor metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler. Thromb. Vasc. 25:754–759, 2005.

    Article  CAS  Google Scholar 

  31. Joner, M., A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48:193–202, 2006.

    Article  PubMed  Google Scholar 

  32. Kadota, K., T. Muramatsu, M. Iwabuchi, S. Saito, Y. Hayashi, Y. Ikari, S. Nanto, K. Fujii, N. Inoue, A. Namiki, T. Kimura, and K. Mitsudo. Randomized comparison of the nobori Biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheter. Cardiovasc. Interv. 80:789–796, 2012.

    Article  PubMed  Google Scholar 

  33. Karjalainen, P. P., A. Ylitalo, J. K. Airaksinen, and W. Nammas. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population. J. Interv. Cardiol. 24:1–8, 2011.

    Article  PubMed  Google Scholar 

  34. Kastrati, A., J. Mehilli, J. Dirschinger, F. Dotzer, H. Schuhlen, F. J. Neumann, M. Fleckenstein, C. Pfafferott, M. Seyfarth, and A. Schomig. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103:2816–2821, 2001.

    Article  CAS  PubMed  Google Scholar 

  35. Kereiakes, D. J., L. A. Cannon, R. L. Feldman, J. J. Popma, R. Magorien, R. Whitbourn, I. M. Dauber, A. C. Rabinowitz, M. W. Ball, B. Bertolet, A. Kabour, M. C. Foster, J. C. Wang, P. Underwood, and K. D. Dawkins. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent. J. Am. Coll. Cardiol. 56:264–271, 2010.

    Article  PubMed  Google Scholar 

  36. King, L., R. A. Byrne, J. Mehilli, A. Schömig, A. Kastrati, and J. Pache. Five-year clinical outcomes for a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent. Catheter. Cardiovasc. Interv. 81:E23–E28, 2013.

    Article  PubMed  Google Scholar 

  37. Koster, R., D. Vieluf, M. Kiehn, M. Sommerauer, J. Kaehler, S. Baldus, T. Meinertz, and C. W. Hamm. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 365:1895–1897, 2000.

    Article  Google Scholar 

  38. Kovandaivelu, K., R. Swaminathan, W. J. Gibson, V. B. Kolachalama, K. L. Nguyen-Ehrenreich, V. L. Giddings, L. Coleman, G. K. Wong, and E. R. Edelman. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123:1400–1409, 2011.

    Article  Google Scholar 

  39. Krucoff, M. W., D. J. Kereiakes, J. L. Petersen, R. Mehran, V. Hasselblad, A. J. Lansky, P. J. Fitzgerald, J. Garg, M. A. Turco, C. A. Simonton, S. Verheye, C. L. Dubois, R. Gammon, W. B. Batchelor, C. D. O’Shaughnessy, J. B. Hermiller, J. Schofer, M. Buchbinder, and W. Wijns. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease. J. Am. Coll. Cardiol. 51:1543–1552, 2008.

    Article  CAS  PubMed  Google Scholar 

  40. Kuramitsu, S., S. Sonodo, H. Yokoi, M. Iwabuchi, Y. Nishizaki, T. Shinozaki, T. Domei, M. Hyodo, K. Inoue, S. Shirai, K. Ando, and M. Nobuyoshi. Long-term cornary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomorgraphy study. Atherosclerosis 237:23–29, 2014.

    Article  CAS  PubMed  Google Scholar 

  41. Kwok, O. H. Stent “Concertina”: stent design does matter. J. Invasive Cardiol. 25(6):E114–E119, 2013.

    PubMed  Google Scholar 

  42. Larsen, K., C. Cheng, D. Tempel, S. Parker, S. Yazdani, W. K. den Dekker, J. H. Houtgraaf, R. De Jong, S. Swager-ten Hoor, E. Ligtenberg, S. R. Hanson, S. Rowland, F. Kolodgie, P. W. Serruys, R. Virmani, and H. J. Duckers. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur. Heart J. 33:120–128, 2012.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Mauri, L., W. Hsieh, J. M. Massaro, K. K. L. Ho, R. D’Agostino, and D. E. Cutlip. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 356:1020–1029, 2007.

    Article  CAS  PubMed  Google Scholar 

  44. Medtronic Press Release. Medtronic to initiate clinical study of Drug-Filled Stent following successful preclinical results, March 14th, 2015.

  45. Mehilli, J., A. Kastrati, R. Wessely, A. Dibra, J. Hausleiter, B. Jaschke, J. Dirschinger, and A. Schomig. Randomized trial of a non-polymer based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late Lumen loss. Circulation 113:273–279, 2006.

    Article  CAS  PubMed  Google Scholar 

  46. Mehran, R., U. Baber, P. G. Steg, C. Ariti, G. Weisz, B. Witzenbichler, T. D. Henry, A. S. Kini, T. Stuckey, D. J. Cohen, P. B. Berger, I. Iakovou, G. Dangas, R. Waksman, D. Antoniucci, S. Sartori, M. W. Krucoff, J. B. Hermiller, F. Shawl, C. M. Gibson, A. Chieffo, M. Alu, D. J. Moliterno, A. Colombo, and S. Pocock. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382:1714–1722, 2013.

    Article  PubMed  Google Scholar 

  47. Migliorini, A., R. Valenti, G. Moschi, G. Parodi, G. Cerisano, P. Buonamici, N. Carrabba, and D. Antoniucci. Predictor of stent thrombosis in patients treated with turbostratic carbon-coated stent implantation for acute myocardial infarction. J. Interv. Cardiol. 23:554–559, 2010.

    Article  PubMed  Google Scholar 

  48. Moravej, M., and D. Mantovani. Biodegradable metals for cardiovascular stent applications: interests and new opportunities. Int. J. Mol. Sci. 12:4250–4270, 2011.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. Mortier, P., and M. De Beule. Stent design back in the picture: an engineering perspective on longitudinal stent compression. EuroIntervention 7:773–775, 2011.

    Article  PubMed  Google Scholar 

  50. Nakazawa, G. Stent thrombosis of drug eluting stent: pathological perspective. J. Cardiol. 58:84–91, 2011.

    Article  PubMed  Google Scholar 

  51. O’Brien, B., and W. Carroll. The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review. Acta Biomater. 5:945–958, 2009.

    Article  PubMed  Google Scholar 

  52. Onuma, Y., and P. W. Serruys. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization. Circulation 123:779–797, 2011.

    Article  PubMed  Google Scholar 

  53. Onuma, Y., P. W. Serruys, J. Gomez, B. de Bruyne, D. Dudek, L. Thuesen, P. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, H. Garcia-Garcia, and J. A. Ormiston. Comparison of in-vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Catheter. Cardiovasc. Interv. 78:3–12, 2011.

    Article  PubMed  Google Scholar 

  54. OrbusNeich Press Release. OrbusNeich Introduces the Combo Dual Therapy Stent at TCT 2011, Nov 10th, 2011.

  55. Ormiston, J. A., A. Abizaid, J. Spertus, J. Fajadet, L. Mauri, J. Schofer, S. Verheye, J. Dens, L. Thuesen, C. Dubois, R. Hoffmann, W. Wijns, P. J. Fitzgerald, J. J. Popma, N. Macours, A. Cebrian, H. P. Stoll, C. Rogers, and C. Spaulding. Six-month results of the NEVO RES-ELUTION I (NEVO RES I) trial. Circ. Cardiovasc. Interv. 3:556–564, 2010.

    Article  CAS  PubMed  Google Scholar 

  56. Ormiston, J. A., P. W. Serruys, Y. Onuma, R. J. van Geuns, B. de Bruyne, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. M. Hebert, R. Rapoza, and H. M. Garcia-Garcia. First serial assessment at 6 months and 2 years for the second generation of absorb everolimus-eluting bioresorbable vascular scaffold. Circ. Cardiovasc. Interv. 5:620–632, 2012.

    Article  CAS  PubMed  Google Scholar 

  57. Pache, J., A. Kastrati, J. Mehilli, H. Schuhlen, F. Dotzer, J. Hausleiter, M. Fleckenstein, F. J. Neumann, U. Sattelberger, C. Schmitt, M. Muller, J. Dirschinger, and A. Schomig. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J. Am. Coll. Cardiol. 41:1283–1288, 2003.

    Article  PubMed  Google Scholar 

  58. Park, K. W. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based zotarolimus-eluting stents in all-comers receiving percutaneous coronary intervention. J. Am. Coll. Cardiol. 63:2805–2816, 2014.

    Article  CAS  PubMed  Google Scholar 

  59. Peuster, M., C. Hesse, T. Schloo, C. Fink, P. Beerbaum, and C. von Schnakenburg. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 27:4955–4962, 2006.

    Article  CAS  PubMed  Google Scholar 

  60. Pilgrim, T., L. Raeber, A. Limacher, L. Loeffel, P. Wenaweser, S. Cook, J. C. Stauffer, M. Togni, R. Vogel, A. Garachemani, A. Moschovitis, A. A. Khattab, C. Seiler, B. Meier, P. Juni, and C. Windecker. Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization. J. Am. Coll. Cardiol. Interv. 4:672–682, 2011.

    Article  Google Scholar 

  61. Prabhu, S., T. Schikorr, T. Mahmoud, J. Jacobs, A. Potgieter, and C. Simonton. Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents. EuroIntervention 8:275–281, 2012.

    Article  PubMed  Google Scholar 

  62. Prunotto, M., C. Vignolini, V. Lolli, A. Black, S. Gaggianesi, A. Santarelli, and M. Galloni. Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model. J. Biomed. Mater. Res. A 88:872–879, 2009.

    Article  CAS  PubMed  Google Scholar 

  63. REVA Medical Press Release. REVA releases initial clinical results from FANTOM scaffold, May 21st, 2015.

  64. Ruef, J., H. Störger, F. Schwarz, and J. Haase. Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real world coronary artery lesions. Catheter. Cardiovasc. Interv. 71:333–339, 2008.

    Article  PubMed  Google Scholar 

  65. Saito, T., S. Hokomito, S. Oshima, K. Noda, Y. Kojyo, and K. Matsunaga. Metal allergic reaction in chronic-refractory in-stent restenosis. Cardiovasc. Revasc. Med. 10:17–22, 2009.

    Article  PubMed  Google Scholar 

  66. Schinhammer, N., A. C. Hänzi, J. F. Löffler, and P. J. Uggowitzer. Design strategy for biodegradable Fe-based alloys for medical applications. Acta Biomater. 6:1705–1713, 2010.

    Article  CAS  PubMed  Google Scholar 

  67. Serruys, P. W., Y. Onuma, D. Dudek, P. C. Smits, J. Koolen, B. Chevalier, B. de Bruyne, L. Thuesen, D. McClean, R. J. van Geuns, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. M. Hebert, K. Sudhir, H. M. Garcia-Garcia, and J. A. Ormiston. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis. J. Am. Coll. Cardiol. 58:1578–1588, 2011.

    Article  CAS  PubMed  Google Scholar 

  68. Sharif, F., S. Hynes, R. Cooney, L. Howard, J. McMahon, K. Daly, J. Crowley, and T. O’Brien. Gene eluting stents: delivery of adenovirus mediated endothelial nitric oxide synthase to the blood vessel wall accelerates re-endothelialization and inhibits restenosis in rabbit iliac arteries. Mol. Ther. 16:1674–1680, 2008.

    Article  CAS  PubMed  Google Scholar 

  69. Sharif, F., S. O. Hynes, K. McCullagh, S. Ganley, U. Geiser, P. McHugh, J. Crowley, F. Barry, and T. O’Brien. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialisation but does not reduce restenosis in a hypercholesterolemic model. Gene Ther. 19:321–328, 2012.

    Article  CAS  PubMed  Google Scholar 

  70. Sharif, F., S. Hynes, J. McMahon, R. Cooney, S. Conroy, P. Dockery, G. Duffy, K. Daly, J. Crowley, J. S. Bartlett, and T. O’Brien. Gene eluting stents: a comparison of adenoviral and adeno-associated viral gene-delivery to the blood vessel wall in vivo. Hum. Gene Ther. 17:741–750, 2006.

    Article  CAS  PubMed  Google Scholar 

  71. Shiratori, Y., S. Brugaletta, L. Allvarez-Contreras, Y. Azpeitia, N. Ospino, S. Gaido, A. Delahanty, A. Santos, V. Martin-Yuste, M. Masotti, P. W. Serruys, S. Windecker, and M. Sabaté. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent. Catheter. Cardiovasc. Interv. 82:428–436, 2013.

    Article  Google Scholar 

  72. Siller-Matula, J. M., I. Tentzeris, B. Vogel, S. Schacherl, R. Jarai, A. Geppert, G. Unger, and K. Huber. Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points. Clin. Res. Cardiol. 99:645–650, 2010.

    Article  CAS  PubMed  Google Scholar 

  73. Stone, G. W., P. S. Teirstein, I. T. Meredith, B. Farah, C. L. Dubois, R. L. Feldman, J. Dens, N. Hagiwara, D. J. Allocco, and K. D. Dawkins. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent. J. Am. Coll. Cardiol. 57:1700–1708, 2011.

    Article  CAS  PubMed  Google Scholar 

  74. Tada, N., R. Virmani, G. Grant, L. Bartlett, A. Black, C. Clavijo, U. Christians, R. Betts, D. Savage, S. H. Su, J. Shulze, and S. Kar. Polymer-free Biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Circ. Cardiovasc. Interv. 3:174–183, 2010.

    Article  CAS  PubMed  Google Scholar 

  75. Tamai, H., K. Igaki, E. Kyo, K. Kosuga, A. Kawashima, S. Matsui, H. Komori, T. Tsuji, S. Motohara, and H. Uehata. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102:399–404, 2000.

    Article  CAS  PubMed  Google Scholar 

  76. Unverdorben, M., B. Sippel, R. Degenhardt, K. Sattler, R. Fries, B. Abt, E. Wagner, H. Koehler, G. Daemgen, M. Scholz, H. Ibrahim, K. H. Tews, B. Hennen, H. K. Berthold, and C. Vallbracht. Comparison of a silicon-carbide coated stent versus a non-coated stent in human beings. Am. Heart J. 145:e17, 2003.

    Article  PubMed  Google Scholar 

  77. Waksman, R. Update on Absorbable Magnesium Stent. Tel Aviv: Innovation in Cardiovascular Interventions, 2009.

    Google Scholar 

  78. Waksman, R., R. Pakala, R. Baffour, R. Seabron, D. Hellinga, R. Chan, S. H. Su, F. Kolodgie, and R. Virmani. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries. Catheter. Cardiovasc. Interv. 80:429–436, 2012.

    Article  PubMed  Google Scholar 

  79. Walter, D. H., M. Cejna, L. Diaz-Sandoval, S. Willis, P. W. Stratford, A. B. Tietz, R. Kirchmair, M. Silver, C. Curry, A. Wecker, Y. S. Yoon, R. Heidenreich, A. Hanley, M. Kearney, F. O. Tio, P. Kuenzler, J. M. Isner, and D. W. Losordo. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 110:36–45, 2004.

    Article  CAS  PubMed  Google Scholar 

  80. Windecker, S., I. Mayer, G. De Pasquale, W. Maier, O. Dirsch, P. De Groot, Y. P. Wu, G. Noll, B. Leskosek, B. Meier, and O. M. Hess. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation 104:928–933, 2001.

    Article  CAS  PubMed  Google Scholar 

Download references

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4